Status:
COMPLETED
Study of ZIO-201 in Advanced Sarcoma
Lead Sponsor:
Alaunos Therapeutics
Conditions:
Advanced Sarcoma
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The study of safety of Isophosphoramide Mustard (IPM) in the treatment of advanced sarcoma.
Eligibility Criteria
Inclusion
- Metastatic and /or unresectable disease state after previous standard chemotherapy
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT00439686
Start Date
February 1 2006
End Date
December 1 2013
Last Update
January 31 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Santa Monica, California, United States
2
Ann Arbor, Michigan, United States